229 related articles for article (PubMed ID: 31642904)
1. Understanding PDE4's function in Alzheimer's disease; a target for novel therapeutic approaches.
Tibbo AJ; Tejeda GS; Baillie GS
Biochem Soc Trans; 2019 Oct; 47(5):1557-1565. PubMed ID: 31642904
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of cyclic nucleotide phosphodiesterases 4 in developing rat lung.
Lopez E; Jarreau PH; Zana E; Franco-Montoya ML; Schmitz T; Evain-Brion D; Bourbon J; Delacourt C; Méhats C
Dev Dyn; 2010 Sep; 239(9):2470-8. PubMed ID: 20652950
[TBL] [Abstract][Full Text] [Related]
3. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase-4 (PDE4) molecular pharmacology and Alzheimer's disease.
Gurney ME; D'Amato EC; Burgin AB
Neurotherapeutics; 2015 Jan; 12(1):49-56. PubMed ID: 25371167
[TBL] [Abstract][Full Text] [Related]
5. UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy.
Wang L; Burmeister BT; Johnson KR; Baillie GS; Karginov AV; Skidgel RA; O'Bryan JP; Carnegie GK
Cell Signal; 2015 May; 27(5):908-22. PubMed ID: 25683917
[TBL] [Abstract][Full Text] [Related]
6. Basal Spontaneous Firing of Rabbit Sinoatrial Node Cells Is Regulated by Dual Activation of PDEs (Phosphodiesterases) 3 and 4.
Vinogradova TM; Sirenko S; Lukyanenko YO; Yang D; Tarasov KV; Lyashkov AE; Varghese NJ; Li Y; Chakir K; Ziman B; Lakatta EG
Circ Arrhythm Electrophysiol; 2018 Jun; 11(6):e005896. PubMed ID: 29880528
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase 4D: an enzyme to remember.
Ricciarelli R; Fedele E
Br J Pharmacol; 2015 Oct; 172(20):4785-9. PubMed ID: 26211680
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase 4 and its inhibitors in inflammatory diseases.
Jin SL; Ding SL; Lin SC
Chang Gung Med J; 2012; 35(3):197-210. PubMed ID: 22735051
[TBL] [Abstract][Full Text] [Related]
10. PDE4D phosphorylation: A coincidence detector integrating multiple signaling pathways.
Mika D; Conti M
Cell Signal; 2016 Jul; 28(7):719-24. PubMed ID: 26562185
[TBL] [Abstract][Full Text] [Related]
11. Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA).
Collins DM; Murdoch H; Dunlop AJ; Charych E; Baillie GS; Wang Q; Herberg FW; Brandon N; Prinz A; Houslay MD
Cell Signal; 2008 Dec; 20(12):2356-69. PubMed ID: 18845247
[TBL] [Abstract][Full Text] [Related]
12. Synergic PDE3 and PDE4 control intracellular cAMP and cardiac excitation-contraction coupling in a porcine model.
Mika D; Bobin P; Lindner M; Boet A; Hodzic A; Lefebvre F; Lechène P; Sadoune M; Samuel JL; Algalarrondo V; Rucker-Martin C; Lambert V; Fischmeister R; Vandecasteele G; Leroy J
J Mol Cell Cardiol; 2019 Aug; 133():57-66. PubMed ID: 31158360
[TBL] [Abstract][Full Text] [Related]
13. PDE4 associates with different scaffolding proteins: modulating interactions as treatment for certain diseases.
McCahill AC; Huston E; Li X; Houslay MD
Handb Exp Pharmacol; 2008; (186):125-66. PubMed ID: 18491051
[TBL] [Abstract][Full Text] [Related]
14. Implications of PDE4 structure on inhibitor selectivity across PDE families.
Ke H
Int J Impot Res; 2004 Jun; 16 Suppl 1():S24-7. PubMed ID: 15224132
[TBL] [Abstract][Full Text] [Related]
15. Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology.
Zahra N; Rafique S; Naveed Z; Nadeem J; Waqas M; Ali A; Shah M; Idrees M
Life Sci; 2024 May; 345():122565. PubMed ID: 38521388
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase-4D Knock-down in the Prefrontal Cortex Alleviates Chronic Unpredictable Stress-Induced Depressive-Like Behaviors and Memory Deficits in Mice.
Wang ZZ; Yang WX; Zhang Y; Zhao N; Zhang YZ; Liu YQ; Xu Y; Wilson SP; O'Donnell JM; Zhang HT; Li YF
Sci Rep; 2015 Jul; 5():11332. PubMed ID: 26161529
[TBL] [Abstract][Full Text] [Related]
17. Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer's disease.
Ricciarelli R; Brullo C; Prickaerts J; Arancio O; Villa C; Rebosio C; Calcagno E; Balbi M; van Hagen BT; Argyrousi EK; Zhang H; Pronzato MA; Bruno O; Fedele E
Sci Rep; 2017 Apr; 7():46320. PubMed ID: 28402318
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases.
Omar F; Findlay JE; Carfray G; Allcock RW; Jiang Z; Moore C; Muir AL; Lannoy M; Fertig BA; Mai D; Day JP; Bolger G; Baillie GS; Schwiebert E; Klussmann E; Pyne NJ; Ong ACM; Bowers K; Adam JM; Adams DR; Houslay MD; Henderson DJP
Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13320-13329. PubMed ID: 31209056
[TBL] [Abstract][Full Text] [Related]
19. Increased isoform-specific phosphodiesterase 4D expression is associated with pathology and cognitive impairment in Alzheimer's disease.
Paes D; Lardenoije R; Carollo RM; Roubroeks JAY; Schepers M; Coleman P; Mastroeni D; Delvaux E; Pishva E; Lunnon K; Vanmierlo T; van den Hove D; Prickaerts J
Neurobiol Aging; 2021 Jan; 97():56-64. PubMed ID: 33157432
[TBL] [Abstract][Full Text] [Related]
20. Protein-protein interactions of PDE4 family members - Functions, interactions and therapeutic value.
Klussmann E
Cell Signal; 2016 Jul; 28(7):713-8. PubMed ID: 26498857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
